DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.19
Tradestie Score
53
Market Cap
$3.50M
Analyst Upside
+236.1%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$2.06
|
$12.21M | 3.1 | 39 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$1.69
|
$8.85M | - | 39 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.49
|
$7.21M | - | 37 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.55
|
$5.01M | - | 46 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$0.99
|
$3.42M | 0.0 | 59 | Compare |
More DRMA Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry